N, T., A, D., E, K., A, H., M, B., I, A., . . . O, S. (2026). Evaluating the impact of cannabis oil for autistic children with and without concomitant medications: Insights from an open-label study. Journal of psychopharmacology (Oxford, England), 40(3), 401. https://doi.org/10.1177/02698811251332841
Chicago Style (17th ed.) CitationN, Treves, et al. "Evaluating the Impact of Cannabis Oil for Autistic Children with and Without Concomitant Medications: Insights from an Open-label Study." Journal of Psychopharmacology (Oxford, England) 40, no. 3 (2026): 401. https://doi.org/10.1177/02698811251332841.
MLA (9th ed.) CitationN, Treves, et al. "Evaluating the Impact of Cannabis Oil for Autistic Children with and Without Concomitant Medications: Insights from an Open-label Study." Journal of Psychopharmacology (Oxford, England), vol. 40, no. 3, 2026, p. 401, https://doi.org/10.1177/02698811251332841.